1Temelkova-Kurktschiev T, Henkel E, Schaper F, et al. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia and underestimated evil? Exp Clin Endocrinol Diabetes, 2000,108:93-99. 被引量：1
2Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33:309-315. 被引量：1
3Stern MP. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes, 1995,44:369-374. 被引量：1
4Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes, 2001,50:2384-2388. 被引量：1
5Verma S, Li SH, Badiwada MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 2002,105:1890-1896. 被引量：1
6Dandona P, Aliada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and athelosclerosis. Am J Cardiol, 2002,90:27G-33G. 被引量：1
7Pickup JC, Crook MA. Is type Ⅱ diabetes mellitus a disease of the innate immune system? Diabetologia, 1998,41:1241-1248. 被引量：1
8Pickup JC, Mattock MB, Chuseney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997,40:1286-1292. 被引量：1
9McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism, 1989,38:1042-1046. 被引量：1
10Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334. 被引量：1
7[4]Torzewski J,Torzewski M,Bowyer DE,et al.Greactive protein Freguenfly colocallzes with the terminal conrplement complex in the intinta ofcarly atherosclcroticlcsions of human coronary artcrics[J].Arteriscley Thromb Vasc Bid,1998,18 (9):1386-1392. 被引量：1
8[5]Gan AJ,Buggle F,Becher H,et al.The association of lcukodyte count,fibririogen and C-reactive protein with Vascular risk and ischemic Vascular diseases[J].Thrombsis Research,1996,82(3):245-255. 被引量：1
